Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma
- Resource Type
- Letter
- Source
- Cancer Immunology, Immunotherapy. 72(9):3133-3134
- Subject
- Language
- English
- ISSN
- 0340-7004
1432-0851